Latest news
Lantheus Holdings (NASDAQ:LNTH) in Focus as Curium Deal Stirs Radiopharma - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 05:56:00 GMTCurium to acquire Lantheus in all-cash deal worth up to $8bn - Pharmaceutical TechnologyPharmaceutical Technology · Tue, 04 Aug 2026 08:57:27 GMTCurium strikes up to $8B deal for radiopharma rival Lantheus - Fierce BiotechFierce Biotech · Mon, 03 Aug 2026 18:20:15 GMTTelix Pharmaceuticals: The Radiopharma Operating System Is The Real Moat (NASDAQ:TLX) - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTCurium Reportedly Nears Acquisition Of Lantheus For Approximately $7 Billion - Pulse 2.0Pulse 2.0 · Thu, 30 Jul 2026 02:22:16 GMTChampions Oncology Q4 Earnings Call Highlights - TradingViewTradingView · Mon, 27 Jul 2026 22:02:44 GMTChampions Oncology reports record $59.4M revenue, positive adjusted EBITDA for FY2026 - TradingViewTradingView · Mon, 27 Jul 2026 20:33:00 GMT